JOIN US ON
HME-forum.com
Join us online for these live, interactive,
expert-led broadcasts.
Register your interest at:
www.HME-forum.com
Please scan here
to register for
the upcoming
webinars
Please note that all events are only open to healthcare professionals
Registration prior to the live event is required in order to
access both the live and archived broadcasts.
Depending on your country, you may not have access to HME Forum.
Registered participants will also be
able to view archived versions of the
broadcasts following the live events.
With the support of Janssen Pharmaceutical
Companies of Johnson & Johnson in EMEA
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, Belgium
EM-41544
Date of Preparation: September 2020
Copyright © 2020 Janssen Pharmaceutica NV
Christian Buske
Germany
Michel Delforge
Belgium
Paolo Ghia
Italy
SCIENTIFIC PROGRAMME
SESSION I
HODGKIN’S DISEASE
DEBATE I
IS THERE STILL A ROLE
FOR COMBINED MODALITY
THERAPY FOR EARLY
STAGE CHL?
SESSION II
T-CELL LYMPHOMA
ROUNDTABLE I
FUTURE DIRECTIONS IN
T-CELL LYMPHOMA
SESSION III
FOLLICULAR LYMPHOMA
DEBATE II
CAN WE AVOID
CHEMOTHERAPY IN
THE MANAGEMENT OF
FOLLICULAR LYMPHOMA?
SESSION IV
RARE LYMPHOMAS –
MARGINAL ZONE
LYMPHOMA AND
WALDENSTRÖM M
ACROGLOBULINEMIA
ROUNDTABLE II – WHERE
TO GO IN RARE B-CELL
LYMPHOMAS
SESSION V
MANTLE CELL LYMPHOMA
SESSION VI
DIFFUSE LARGE B-CELL
LYMPHOMA
DEBATE III
DO WE STILL NEED ASCT
IN MCL?
SESSION VII
NOVEL THER APEUTIC
CONCEPTS IN B-CELL
LYMPHOMAS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
DISCLOSURES